Results 161 to 170 of about 95,190 (307)

Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells [PDF]

, 1989
H. Drexler, SM Gignac, RA Jones, Scott Cs, GR Pettit, A. V. Hoffbrand   +5 more
openalex   +1 more source

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
Erin Hickey Zacholski, Jack Dierckes, David Hartnett‐Quach, Cady Noda, Amanda Sharps, Olivia White, Kyle Zacholski, Shawn P. Griffin   +7 more
wiley   +1 more source

Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia. [PDF]

Blood Adv
Ramassone A, Pagotto S, Di Marco M, Rashid MM, Di Camillo C, Palmiero F, Innocenti I, Autore F, Tomasso A, Laurenti L, Visone R.   +10 more
europepmc   +1 more source

Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety [PDF]

, 1986
O Ayanlar-Batuman, E Ebert, SP Hauptman
openalex   +1 more source

Bifenthrin Under Scrutiny: Revisiting Toxicological Evidence Amid Regulatory Gaps

Journal of Applied Toxicology, EarlyView.
ABSTRACT Despite growing health concerns, bifenthrin (BF) remains widely used for controlling agricultural and residential pests. However, different perspectives on its toxicological profile and regulatory framework warrant a revisit and update on BF regulation towards a robust risk‐safety assessment.
Caroline V. L. Moreira, John Ogbu I, Kadja L. C. Monteiro, Thiago M. de Aquino, Edeildo F. da Silva‐Júnior, Alberto S. S. Filho, Hamilton B. Napolitano, Christianah A. Elusiyan, Renê O. do Couto, Elson A. Costa, James O. Fajemiroye   +10 more
wiley   +1 more source

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report. [PDF]

Front Oncol
Lv Z, Lu P, Jing C, Yi X, Wu X.
europepmc   +1 more source

Interleukin 2 stimulates chronic lymphocytic leukemia colony formation in vitro [PDF]

, 1985
Ivo P. Touw, Bob Löwenberg
openalex   +1 more source

Chronic lymphocytic leukemia

Hematology, 2015
openaire   +3 more sources

Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group

Journal of Clinical Laboratory Analysis, EarlyView.
Our study proposed a practical set of customized flow cytometry markers that enhance the diagnosis of CLL by improving both sensitivity and accuracy. Moreover, these markers hold significant prognostic value. The identification of relapse‐associated markers provides critical insights to inform personalized treatment and monitoring strategies.
Ornnicha Sathitakorn, Sirorat Kobbuaklee, Chantiya Chanswangphuwana, Thanawat Rattanathammethee, Nisa Makruasi, Anothai Chintabanyat, Suporn Chuncharunee, Pisa Phiphitaporn, Archrob Khuhapinant, Peerapon Wong, Jakrawadee Julamanee, Chayapa Thookhamme, Lalita Norasetthada, Udomsak Bunworasate, Kitsada Wudhikarn, Tanin Intragumtornchai, Chantana Polprasert   +16 more
wiley   +1 more source

MLR Corresponds to the Functional Status of Monocytes in Chronic Lymphocytic Leukemia. [PDF]

Int J Inflam
Grzegorzewska W, Zarobkiewicz M, Jastrzębska-Pawłowska K, Lehman N, Tomczak W, Mizerska-Kowalska M, Bojarska-Junak A, Roliński J.   +7 more
europepmc   +1 more source